Latest posts from
What is New in Respiratory Medicine
Facebook Group
-
Wednesday 16 Sep 2020
Low socioeconomic status relates to asthma and wheeze, especially in women.
The different indicators of socioeconomic status illustrated various aspects of associations between low socioeconomic status (SES) and asthma and wheeze, and the most prominent associations were found among women.
Low socioeconomic status (SES) has been associated with asthma and wheezing. Occupational group, educational level and income are commonly used indicators for SES, but no single indicator can illustrate the entire complexity of SES. The aim was to investigate how different indicators of SES associat...
-
Wednesday 16 Sep 2020
Response to mepolizumab treatment is sustained across 4-weekly dosing periods.
The response to mepolizumab is sustained over the 4-weekly dosing period with no differences across a 10-fold dose range and supports the use of the current mepolizumab dosing regimen in patients with severe eosinophilic asthma.
openres.ersjournals.com
Response to mepolizumab treatment is sustained across 4-weekly dosing periods
Background Mepolizumab (100 mg delivered s.c. every 4 weeks) is indicated for add-on maintenance treatment for patients with severe eosinophilic asthma. Mepolizumab has been shown to reduce exacerbations and the requirement for daily oral corticosteroids, and improve asthma control and symptoms. H...
-
Wednesday 16 Sep 2020
Personalised exhaled nitric oxygen fraction (FENO)-driven asthma management in primary care: a FENO subgroup analysis of the ACCURATE trial
In primary care, FENO-driven asthma management is effective in patients with a low FENO level, for whom it is possible to down-titrate medication, while preserving asthma control and quality of life.
Background The aim of this study was to identify patients who benefit most from exhaled nitric oxide fraction ( F ENO)-driven asthma management in primary care, based on prespecified subgroups with different levels of F ENO. Methods We used data from 179 adults with asthma from a 12-month primary ca...
-
Wednesday 16 Sep 2020
Predictors of massive haemoptysis after a first episode of mild-to-moderate haemoptysis in patients with cystic fibrosis.
Allergic bronchopulmonary aspergillosis (ABPA), metabolic disorders, such as diabetes, and recurrent mild-to-moderate haemoptysis may predict massive haemoptysis (MH) occurrence in cystic fibrosis (CF) patients with at least one mild-to-moderate haemoptysis episode.
The main cause of death of cystic fibrosis (CF) patients is respiratory disease due to secondary infections, haemoptysis, pneumothorax, and respiratory failure [1]. In a study of 129 French CF patients who died between 2007 and 2010 without receiving lung transplantation, 8.5% of deaths were due to....
-
Wednesday 16 Sep 2020
Dramatic Clinical Improvement in Nine Consecutive Acutely Ill Elderly COVID-19 Patients Treated with a Nicotinamide Mononucleotide Cocktail: A Case Series.
Nicotinamide adenine dinucleotide (NAD+) - a coenzyme found in every cell in the human body - is involved in hundreds of critical metabolic processes. However, as humans age, intracellular NAD+ levels decrease - this depletion appears to be exacerbated during complicated SARS-COV-2 infections. NAD+ depletion impairs our antiviral defense systems and our ability to optimally control inflammation. The NMN cocktail resulted in rapid and dramatic clinical and laboratory improvement in older persons with complicated SARS-CoV-2 infections.
Background: Nicotinamide adenine dinucleotide (NAD+) - a coenzyme found in every cell in the human body - is involved in hundreds of critical metabolic processe
-
Tuesday 15 Sep 2020
Coughs and Sneezes: Their Role in Transmission of Respiratory Viral Infections, Including SARS-CoV-2
The slogan “Coughs and Sneezes Spread Diseases” was coined in the United States during the last great flu pandemic between 1918 and 1920 to highlight the role of coughs and sneezes in disseminating respiratory pathogens. A cough produces approximately 3,000 droplets, whereas a sneeze releases an...
-
Tuesday 15 Sep 2020
We are almost there - WiNRespMed Ioannina 2020 DOWNLOAD the APP (for Android and iOS) ...to join the Congress but also the WiNRespMed community... STAY TUNED!!!
Download the WiNRespMed app and carry the congress in your pocket.
-
Tuesday 15 Sep 2020
Do not miss the Opening session on September 18th at 09.00 – 11.00 EEST on #LungCancer chaired by our distinguished panel M.Gaga (GR), T. Kontakiotis (GR), I. Dimitroulis (GR) and our expert speakers J. Chorostowska-Wynimko (PL), D. Spyratos (GR), V. Skouras (GR), K. Samitas (GR).
Morning sessions on Friday will also include at 11.30 – 13.30 EEST #SleepDisorders chaired by A.Konstantinidis (GR), G. Daskalopoulos (GR) and A. Dervas(GR) with invited speakers R. Schiza (GR), A. Pataka (GR), A. Konstantinidis (GR), P. Steiropoulos (GR).
Find out more about the program and registration process: https://respiratory-ioannina.com/winrespmed2020
-
Tuesday 15 Sep 2020
It is theoretically possible to contract COVID off surfaces, but highly unlikely, says one pediatric infectious diseases doctor. Most people in their everyday lives don't have to obssess over surfaces.
-
Tuesday 15 Sep 2020
Guidance for adjustment of sarcoidosis management during the COVID-19 pandemic: https://hubs.ly/H0wbHVF0
-
Monday 14 Sep 2020
In rush to embrace telehealth, many physicians still have concerns about quality of care, survey finds | FierceHealthcare
During the height of the COVID-19 pandemic, doctors turned to virtual consultations to continue to provide care to their patients. But close to 60% of physicians have lingering reservations about the quality of care they can provide remotely, according to a recent survey.
-
Monday 14 Sep 2020
Whole new episode of #OutOfTheBlue ready for you to download! Use of Hydrocortisone, Ascorbic Acid, and Thiamine in Adults with Septic Shock | Out of the Blue: An AJRCCM Podcast
The Out of the Blue podcast takes you out of the pages of the American Journal of Respiratory and Critical Care Medicine and into the minds of the most brilliant researchers in the fields of respiratory, critical care, and sleep medicine.
-
Monday 14 Sep 2020
Blue Briefing: Pulmonary Angiopathy in COVID-19 - Physiologic, Imaging and Hematologic Observations - YouTube
In a new paper published in The American Journal of Respiratory and Critical Care Medicine, pulmonary and critical care experts report that the enlargement o...
-
Monday 14 Sep 2020
What is New in Respiratory Medicine - September 18-20
We are almost there for our comprehensive CLINICAL YEAR IN REVIEW in all topics of modern Respiratory Medicine
- 11 clinical and 2 keynote lectures sessions
- 46 internationally acknowledged speakers
- 39 experienced chairs to moderate interactive discussion
Friday 18 September
- Lung Cancer
- Sleep Disorders
- Non-Invasive Ventilation
- Respiratory Infections
- Asthma
Saturday 19 September
- Interventional Pulmonology
- COVID-19 Management
- Keynote Lectures (RWE, What Is New in the Blue)
- Interstitial Lung Disease
- Pulmonary Vascular Disease and Transplantation
Sunday 20 September
- Challenging Clinical Problems
- COPD
- Keynote Lectures (Digital Severe Asthma, Palliative Care)
Kindly note that the congress has been accredited by the Panhellenic Medical Association with 22 CME credits. Participants can claim only the credits according the time spent on line for each session.
-
Monday 14 Sep 2020
Όπως ήδη γνωρίζετε η Πνευμονολογική Κλινική του Πανεπιστημίου Ιωαννίνων διοργανώνει με την Ένωση Πνευμονολόγων Ελλάδας το διεθνές συνέδριο με τίτλο “What is New in Res...
-
Sunday 13 Sep 2020
A Likert score based on chest radiography of symptomatic patients of #COVID19 can be used as a diagnostic and triaging tool in the emergency room to help physicians identify patients with likelihood of COVID-19 and triage them appropriately buff.ly/3hz7hmp
The number of patients with severe acute respiratory syndrome coronavirus 2 (coronavirus disease 2019 (COVID-19)) infection continues to rise globally. Physicians across specialties continue to play a pivotal role in the diagnosis and management of this disease. Early diagnosis with good sensitivity...
-
Sunday 13 Sep 2020
Recent reports have demonstrated a decline in IgG neutralizing antibodies to SARS-CoV-2 in convalescence, raising concerns of susceptibility to reinfection. But antibody levels always decline after the acute phase of infection, and after the reduction, serological memory is maintained by a smaller number of long-lived plasma cells that reside in the bone marrow and that secrete antibody in the absence of antigen. Antibody recall responses come from this pool of long-lived memory B cells. .https://ja.ma/3bYRBHS
This Viewpoint reviews what is known about acute and long-term B-cell, antibody, and T-cell responses to SARS-CoV-2 infection and explains how each are implicated in vaccine candidates likely to be effective and durably protective again COVID-19.
-
Saturday 12 Sep 2020
Oral Masitinib Phase 3 Results Promising for Severe Asthma buff.ly/33c8gU6… via @medscape
The tyrosine kinase inhibitor reduced severe exacerbations by 35%, regardless of eosinophil count, in a population that hasn't had an effective oral treatment option, new research shows.
-
Saturday 12 Sep 2020
Children with COVID-19 had similar rates of hospitalization, ICU admission, and ventilator use as children with influenza but were older and more likely to have underlying conditions, new data showed.
-
Saturday 12 Sep 2020
Great to see this paper. Pregnancy does not impact CF disease progression even in severe disease.
Over the past decades advances in Cystic fibrosis (CF) patient care have led to an improvement in patient survival, with the majority of patients reaching adulthood [1]. This improvement was accompanied by an increase in the quality of life [2]. One result of these changes in longevity, and quality....
